GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (ASX:MYX) » Definitions » Accounts Receivable

Mayne Pharma Group (ASX:MYX) Accounts Receivable : A$185.0 Mil (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Mayne Pharma Group Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Mayne Pharma Group's accounts receivables for the quarter that ended in Jun. 2024 was A$185.0 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Mayne Pharma Group's Days Sales Outstanding for the quarter that ended in Jun. 2024 was 167.98.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Mayne Pharma Group's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was A$-4.48.


Mayne Pharma Group Accounts Receivable Historical Data

The historical data trend for Mayne Pharma Group's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Accounts Receivable Chart

Mayne Pharma Group Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 192.61 173.94 260.03 186.82 184.96

Mayne Pharma Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 260.03 246.76 186.82 184.68 184.96

Mayne Pharma Group Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Mayne Pharma Group Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Mayne Pharma Group's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=184.964/200.958*91
=167.98

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Mayne Pharma Group's accounts receivable are only considered to be worth 75% of book value:

Mayne Pharma Group's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(149.278+0.75 * 184.964+0.5 * 74.629-688.989
-0-0)/81.2458
=-4.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Mayne Pharma Group Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Mayne Pharma Group Business Description

Traded in Other Exchanges
Address
1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women's health products in the US. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.